当前位置:首页 - 行情中心 - 亚宝药业(600351) - 财务分析

亚宝药业

(600351)

  

流通市值:42.42亿  总市值:42.42亿
流通股本:7.00亿   总股本:7.00亿

亚宝药业(600351)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.06亿元,每股收益0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益294346.61万元,未分配利润135918.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产356913.51万元,负债62566.90万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入614,533,394.312,686,037,568.672,121,509,818.791,443,686,437.98
营业总成本490,742,317.932,391,542,009.251,854,942,934.531,246,402,129.14
营业利润128,321,980.34299,953,120.02288,373,771.98212,141,585.97
利润总额128,305,385.06292,108,127.74284,011,333.98212,806,112.58
净利润106,068,467.86223,915,500.69228,467,854.51175,191,777.35
其他综合收益--1,288,990.13--
综合收益总额106,068,467.86222,626,510.56228,467,854.51175,191,777.35
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,613,879,508.731,559,311,767.721,657,708,555.211,709,637,384.53
非流动资产合计1,955,255,613.141,984,630,806.622,035,526,473.522,044,303,637.79
资产总计3,569,135,121.873,543,942,574.343,693,235,028.733,753,941,022.32
流动负债合计558,893,177.67582,015,284.21637,351,004.55792,686,232.96
非流动负债合计66,775,801.7767,007,760.3471,059,923.7472,434,242.34
负债合计625,668,979.44649,023,044.55708,410,928.29865,120,475.3
归属于母公司股东权益合计2,942,386,032.982,892,638,654.662,952,235,544.542,876,285,769.93
股东权益合计2,943,466,142.432,894,919,529.792,984,824,100.442,888,820,547.02
负债和股东权益合计3,569,135,121.873,543,942,574.343,693,235,028.733,753,941,022.32
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计556,005,952.752,587,012,203.251,899,547,705.511,348,100,467.12
经营活动现金流出小计411,607,424.32,115,317,630.431,517,127,355.831,005,959,916.85
经营活动产生的现金流量净额144,398,528.45471,694,572.82382,420,349.68342,140,550.27
投资活动现金流入小计5,190,953.8924,804,609.526,908,988.166,123,891.02
投资活动现金流出小计32,047,729.1258,456,812.5745,704,795.3130,855,842.16
投资活动产生的现金流量净额-26,856,775.23-33,652,203.05-38,795,807.15-24,731,951.14
筹资活动现金流入小计90,000,000133,742,947.96133,742,947.9690,000,000
筹资活动现金流出小计150,586,458.42559,009,463.93491,823,805.79376,671,195.19
筹资活动产生的现金流量净额-60,586,458.42-425,266,515.97-358,080,857.83-286,671,195.19
汇率变动对现金及现金等价物的影响41,220.918,404.6947,145.4949,690.21
现金及现金等价物净增加额56,996,515.712,794,258.49-14,409,169.8130,787,094.15
期末现金及现金等价物余额635,254,516.8578,258,001.1551,054,572.8596,250,836.76
TOP↑